0001209191-15-066178.txt : 20150814 0001209191-15-066178.hdr.sgml : 20150814 20150814203919 ACCESSION NUMBER: 0001209191-15-066178 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150812 FILED AS OF DATE: 20150814 DATE AS OF CHANGE: 20150814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 887 GREAT NORTHERN WAY STREET 2: SUITE 450 CITY: VANCOUVER STATE: A1 ZIP: V5T 4T5 BUSINESS PHONE: 604-629-9223 MAIL ADDRESS: STREET 1: 887 GREAT NORTHERN WAY STREET 2: SUITE 450 CITY: VANCOUVER STATE: A1 ZIP: V5T 4T5 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MacKenzie Lloyd CENTRAL INDEX KEY: 0001600164 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 151057589 MAIL ADDRESS: STREET 1: C/O AQUINOX PHARMACEUTICALS, INC. STREET 2: 450 - 887 GREAT NORTHERN WAY CITY: VANCOUVER STATE: A1 ZIP: V5T 4T5 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-12 0 0001404644 AQUINOX PHARMACEUTICALS, INC AQXP 0001600164 MacKenzie Lloyd C/O AQUINOX PHARMACEUTICALS, INC. 450 - 887 GREAT NORTHERN WAY VANCOUVER A1 V5T 4T5 BRITISH COLUMBIA, CANADA 0 1 0 0 VP Technical Operations Common Stock 2015-08-12 4 M 0 7812 5.76 A 7812 D Common Stock 2015-08-12 4 M 0 28075 5.76 A 35887 D Common Stock 2015-08-12 4 S 0 35887 18.67 D 0 D Stock Option (Right to Buy) 5.76 2015-08-12 4 M 0 7812 0.00 A 2020-06-10 Common Stock 7812 0 D Stock Option (Right to Buy) 5.76 2015-08-12 4 M 0 28075 0.00 A 2021-11-10 Common Stock 28075 1872 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.775 to $20.43. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price withinh the ranges set in this footnote. Fully vested. The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of the vesting commencement date and 1/48th of the total number of shares underlying the options each monthly anniversary of the vesting commencement date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the vesting commencement date. /s/ Lloyd Mackenzie 2015-08-14